Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
CLYM	CLIMB BIO INC	$134.85M	-23.10%	-22.50%	-25.11%	-35.50%	0.04	14.08	N/A	N/A	N/A
BCAX	BICARA THERAPEUTICS INC	$756.79M	-21.70%	-20.90%	-23.46%	5,046.80%	0.04	25.80	N/A	N/A	N/A
CRSP	CRISPR THERAPEUTICS AG	$5.80B	-25.20%	-21.50%	-24.09%	-22.70%	0.19	16.61	100.00%	-1,229.40%	-1,218.98%
ENLV	ENLIVEX THERAPEUTICS LTD	$24.10M	-58.30%	-50.30%	-79.72%	-2,051.00%	0.19	6.41	N/A	N/A	N/A
AVR	ANTERIS TECHNOLOGIES GLOBAL CORP	$157.23M	-251.30%	-167.50%	-316.00%	3,233.80%	0.65	2.42	59.40%	-3,385.60%	-3,382.86%
DNTH	DIANTHUS THERAPEUTICS INC	$1.27B	-29.30%	-27.90%	-30.38%	-40.00%	0.06	15.99	100.00%	-1,544.00%	-1,544.02%
TRDA	ENTRADA THERAPEUTICS INC	$222.14M	-17.80%	-14.60%	-17.93%	-17.40%	0.18	18.64	100.00%	-92.30%	-96.77%
VTAK	CATHETER PRECISION INC	$3.14M	-245.00%	-91.80%	-82.39%	4,791.10%	2.80	0.44	92.30%	-4,010.00%	-2,872.67%
SDGR	SCHRODINGER INC	$1.48B	-45.70%	-24.80%	-33.83%	-39.00%	1.01	3.30	58.50%	-76.20%	-75.72%
ZURA	ZURA BIO LTD	$194.40M	-46.40%	-37.40%	-48.71%	396.20%	0.15	8.40	N/A	N/A	N/A
CRDL	CARDIOL THERAPEUTICS INC	$94.25M	-232.70%	-158.50%	-315.14%	673.60%	0.69	2.47	N/A	N/A	N/A
XAIR	BEYOND AIR INC	$12.80M	-243.20%	-115.90%	-168.22%	-138.90%	1.78	3.24	-24.60%	-880.70%	-826.24%
ACLX	ARCELLX INC	$4.36B	-35.30%	-22.70%	-36.07%	-35.20%	0.56	4.93	100.00%	-211.50%	-251.56%
GLMD	GALMED PHARMACEUTICALS LTD	$7.37M	-48.30%	-43.00%	-45.36%	-78.30%	0.12	8.71	N/A	N/A	N/A
RCEL	AVITA MEDICAL INC	$141.95M	-632.60%	-71.70%	-111.11%	-59.90%	-16.20	2.09	85.50%	-79.60%	-72.25%
ICCM	ICECURE MEDICAL LTD	$59.79M	-241.10%	-125.80%	-537.63%	-14,451.00%	2.66	1.18	35.90%	-559.00%	-569.07%
RBOT	VICARIOUS SURGICAL INC	$32.23M	-147.50%	-97.60%	-166.59%	-98.30%	0.77	5.11	N/A	N/A	N/A
SLDB	SOLID BIOSCIENCES INC	$464.88M	-71.90%	-58.50%	-55.23%	-113.40%	0.19	9.34	N/A	N/A	N/A
DSGN	DESIGN THERAPEUTICS INC	$390.09M	-27.10%	-26.10%	-29.65%	-29.50%	0.05	25.13	N/A	N/A	N/A
ACRV	ACRIVON THERAPEUTICS INC	$57.25M	-50.80%	-46.10%	-59.22%	-64.10%	0.11	10.31	N/A	N/A	N/A
VIR	VIR BIOTECHNOLOGY INC	$782.10M	-50.20%	-40.80%	-50.57%	-55.80%	0.26	7.01	96.10%	-2,895.90%	-2,894.48%
QNCX	QUINCE THERAPEUTICS INC	$86.48M	-186.10%	-42.10%	-44.55%	-92.30%	8.99	5.00	N/A	N/A	N/A
PDSB	PDS BIOTECHNOLOGY CORP	$47.10M	-184.60%	-79.00%	-118.39%	-336.00%	1.54	2.92	N/A	N/A	N/A
CARL	CARLSMED INC	$357.52M	N/A	N/A	N/A	N/A	-0.33	4.87	N/A	N/A	N/A
INO	INOVIO PHARMACEUTICALS INC	$129.67M	-158.30%	-93.40%	-240.23%	-230.40%	1.39	1.66	100.00%	-48,131.40%	-48,131.35%
DBVT	DBV TECHNOLOGIES SA	$250.47M	-287.20%	-138.80%	-130.09%	-1,400.20%	0.66	2.45	100.00%	-3,220.50%	-3,217.23%
SLN	SILENCE THERAPEUTICS PLC	$267.55M	N/A	-41.50%	-49.42%	-85.60%	-0.76	10.06	78.50%	-290.10%	-271.70%
QCLS	Q/C TECHNOLOGIES INC	$7.21M	-103.90%	-51.70%	-59.60%	-203.20%	1.05	0.93	N/A	N/A	N/A
NUVL	NUVALENT INC	$6.12B	-33.20%	-30.70%	-35.51%	-39.70%	0.11	13.57	N/A	N/A	N/A
CVRX	CVRX INC	$203.46M	-79.30%	-41.00%	-42.66%	-70.20%	1.06	11.99	83.50%	-95.60%	-85.77%
HCWB	HCW BIOLOGICS INC	$8.26M	N/A	-77.00%	-506.13%	-115.00%	-557.25	0.11	100.00%	-12,940.00%	-6,270.17%
CGEN	COMPUGEN LTD	$134.69M	-34.80%	-16.80%	-17.27%	-68.00%	1.12	4.74	62.30%	-87.40%	-67.02%
KYTX	KYVERNA THERAPEUTICS INC	$256.88M	-64.90%	-56.10%	-84.94%	-89.40%	0.23	5.39	N/A	N/A	N/A
CBIO	CRESCENT BIOPHARMA INC	$170.74M	-103.40%	-86.60%	-28.51%	773.10%	0.13	9.21	N/A	N/A	N/A
ELVN	ENLIVEN THERAPEUTICS INC	$1.20B	-29.20%	-27.90%	-20.51%	-43.10%	0.03	32.58	N/A	N/A	N/A
EYPT	EYEPOINT PHARMACEUTICALS INC	$966.80M	-54.30%	-41.80%	-45.71%	-62.60%	0.22	7.85	93.30%	-261.90%	-261.73%
SABS	SAB BIOTHERAPEUTICS INC	$18.12M	-105.10%	-69.20%	-119.31%	-94.10%	0.78	1.69	100.00%	-9,071.80%	-8,989.31%
SPRC	SCISPARC LTD	$2.30M	79.70%	58.40%	74.02%	127.40%	0.17	5.36	38.70%	481.20%	507.12%
MRSN	MERSANA THERAPEUTICS INC	$38.88M	N/A	-57.90%	-278.51%	-11,474.40%	-2.59	1.35	100.00%	-212.90%	-202.14%
EWTX	EDGEWISE THERAPEUTICS INC	$1.66B	-30.60%	-29.20%	-25.44%	-33.10%	0.04	28.87	N/A	N/A	N/A
CMPS	COMPASS PATHWAYS PLC	$563.18M	-78.30%	-51.40%	-50.29%	-230.70%	0.81	8.82	N/A	N/A	N/A
OSCR	OSCAR HEALTH INC	$4.95B	-13.80%	-3.00%	-8.44%	204.40%	4.51	0.89	17.20%	-1.50%	-1.20%
HYPD	HYPERION DEFI INC	$58.31M	-878.40%	-182.10%	-83.30%	-315.90%	0.49	0.91	-7,177.30%	-90,270.20%	-85,006.99%
SRTS	SENSUS HEALTHCARE INC	$52.11M	-1.60%	-1.40%	-0.94%	-1.50%	0.13	8.14	52.20%	-2.30%	-1.31%
COYA	COYA THERAPEUTICS INC	$94.66M	-61.00%	-53.60%	-72.74%	-4,038.90%	0.18	7.43	100.00%	-4,803.10%	-4,973.22%
JBIO	JADE BIOSCIENCES INC	$281.24M	-52.00%	-47.60%	-27.81%	-211.00%	0.11	10.31	N/A	N/A	N/A
BDSX	BIODESIX INC	$56.75M	-269.70%	-43.90%	-46.43%	-33.90%	76.10	2.14	78.80%	-53.70%	-44.02%
ATXS	ASTRIA THERAPEUTICS INC	$415.36M	-38.60%	-36.10%	-44.31%	-47.90%	0.08	14.89	N/A	N/A	N/A
IRON	DISC MEDICINE INC	$2.26B	-26.60%	-24.60%	-22.12%	-32.80%	0.08	32.11	N/A	N/A	N/A
SY	SO-YOUNG INTERNATIONAL INC	$395.30M	-33.70%	-23.20%	-32.19%	-61.80%	0.45	2.55	55.50%	-46.30%	-46.00%
XENE	XENON PHARMACEUTICALS INC	$3.01B	-38.50%	-36.50%	-44.07%	-45.70%	0.06	15.14	100.00%	-3,709.70%	-3,767.93%
APLT	APPLIED THERAPEUTICS INC	$88.14M	-231.60%	-94.20%	-345.73%	218.80%	1.14	1.94	100.00%	-55,523.80%	-55,523.77%
CERO	CERO THERAPEUTICS HOLDINGS INC	$6.33M	N/A	-623.40%	995.62%	382.90%	-4.80	0.56	N/A	N/A	N/A
GLSI	GREENWICH LIFESCIENCES INC	$138.48M	-700.90%	-455.70%	-1,249.93%	1,302.30%	1.17	1.85	N/A	N/A	N/A
DCGO	DOCGO INC	$136.76M	-0.20%	-0.10%	2.13%	3.30%	0.42	2.44	34.00%	-0.10%	1.32%
ANVS	ANNOVIS BIO INC	$39.75M	-206.00%	-158.30%	-162.26%	18,400.10%	0.17	7.65	N/A	N/A	N/A
CMPX	COMPASS THERAPEUTICS INC	$528.24M	-53.10%	-46.10%	-60.32%	-65.30%	0.25	7.66	N/A	N/A	N/A
TERN	TERNS PHARMACEUTICALS INC	$681.71M	-27.40%	-26.20%	-29.75%	-57.20%	0.05	24.70	N/A	N/A	N/A
NGNE	NEUROGENE INC	$252.76M	-33.30%	-30.30%	-29.94%	-44.10%	0.09	18.07	N/A	N/A	N/A
NKTR	NEKTAR THERAPEUTICS	$731.02M	-262.10%	-43.90%	-57.01%	-34.20%	17.65	3.24	74.60%	-152.50%	-121.08%
NYXH	NYXOAH SA	$166.21M	-80.40%	-55.80%	-67.34%	-101.10%	0.59	2.63	65.30%	-1,564.90%	-1,304.07%
PLSE	PULSE BIOSCIENCES INC	$1.20B	-65.30%	-56.80%	-61.14%	-659.50%	0.15	12.05	N/A	N/A	N/A
TVGN	TEVOGEN BIO HOLDINGS INC	$155.00M	N/A	-782.00%	822.83%	1,528.10%	-1.45	0.26	N/A	N/A	N/A
BNTC	BENITEC BIOPHARMA INC	$367.24M	-45.30%	-43.00%	-35.41%	1,445.40%	0.02	54.67	N/A	N/A	N/A
PHVS	PHARVARIS NV	$1.33B	-69.10%	-63.40%	N/A	-1,679.00%	0.14	N/A	N/A	N/A	N/A
OCUL	OCULAR THERAPEUTIX INC	$2.18B	-70.00%	-48.00%	-50.05%	-212.70%	0.48	10.10	89.40%	-382.50%	-360.75%
IBIO	IBIO INC	$16.45M	-126.90%	-83.10%	-106.36%	-250.50%	0.56	1.59	100.00%	-4,594.30%	-4,541.25%
BEAM	BEAM THERAPEUTICS INC	$2.42B	-43.20%	-31.10%	-32.75%	-42.50%	0.33	6.75	100.00%	-661.30%	-661.31%
JANX	JANUX THERAPEUTICS INC	$1.40B	-9.30%	-8.90%	-7.52%	-10.40%	0.04	58.47	100.00%	-832.70%	-832.71%
DNLI	DENALI THERAPEUTICS INC	$2.12B	-40.80%	-36.40%	-44.55%	-41.50%	0.14	10.27	N/A	N/A	N/A
STEX	STREAMEX CORP	$171.86M	N/A	-90.20%	752.69%	89.60%	-31.30	0.03	100.00%	-201,892.30%	-201,430.77%
ATON	ALPHATON CAPITAL CORP	$9.14M	-347.70%	-135.50%	-602.49%	2,165.50%	-24.81	2.02	N/A	N/A	N/A
REVB	REVELATION BIOSCIENCES INC	$459.41k	-505.40%	-194.70%	-500.15%	330.90%	0.38	3.61	N/A	N/A	N/A
LXEO	LEXEO THERAPEUTICS INC	$359.65M	-94.70%	-73.40%	-78.94%	-163.10%	0.27	4.43	N/A	N/A	N/A
TARA	PROTARA THERAPEUTICS INC	$170.15M	-36.90%	-33.80%	-34.56%	-83.20%	0.09	12.82	N/A	N/A	N/A
AVIR	ATEA PHARMACEUTICALS INC	$249.89M	-31.30%	-29.30%	-33.14%	-42.80%	0.07	19.94	N/A	N/A	N/A
BBNX	BETA BIONICS INC	$863.10M	N/A	N/A	N/A	N/A	0.09	14.68	N/A	N/A	N/A
VRDN	VIRIDIAN THERAPEUTICS INC	$1.76B	-55.10%	-49.90%	-64.39%	-64.00%	0.13	11.01	100.00%	-112,806.90%	-111,835.74%
VERU	VERU INC	$54.21M	-137.20%	-81.60%	-155.40%	-430.50%	0.78	2.42	40.40%	-491.40%	-482.04%
BTAI	BIOXCEL THERAPEUTICS INC	$38.14M	N/A	-134.40%	460.17%	-40.30%	-1.24	0.76	-144.60%	-5,869.80%	-4,022.24%
SILO	SILO PHARMA INC	$7.05M	-94.40%	-68.60%	-87.28%	-305.10%	0.35	6.07	91.90%	-6,789.20%	-6,782.19%
TAOX	TAO SYNERGIES INC	$21.90M	-283.90%	-154.10%	-150.95%	-1,705.40%	0.11	20.51	100.00%	-735,871.70%	-717,300.61%
FDMT	4D MOLECULAR THERAPEUTICS INC	$389.97M	-40.10%	-36.40%	-44.68%	-49.60%	0.13	8.75	100.00%	-594,375.80%	-594,375.76%
CRNX	CRINETICS PHARMACEUTICALS INC	$4.08B	-30.90%	-28.10%	-25.17%	-35.80%	0.09	22.53	100.00%	-43,191.10%	-43,191.05%
RZLT	REZOLUTE INC	$843.64M	-65.00%	-58.90%	-45.49%	-86.50%	0.08	14.37	N/A	N/A	N/A
ONCO	ONCONETIX INC	$4.96M	-350.60%	-143.40%	-685.85%	819.20%	2.16	0.07	66.40%	-3,458.20%	-3,321.76%
SMMT	SUMMIT THERAPEUTICS INC	$15.72B	-208.60%	-181.30%	-279.62%	-375.80%	0.25	5.13	N/A	N/A	N/A
MGX	METAGENOMI INC	$86.33M	-38.80%	-27.80%	-37.78%	-31.50%	0.39	6.36	100.00%	-258.00%	-267.38%
VNDA	VANDA PHARMACEUTICALS INC	$290.13M	-12.90%	-10.50%	-16.89%	-25.70%	0.29	3.25	94.40%	-32.90%	-41.77%
CCCC	C4 THERAPEUTICS INC	$158.71M	-53.90%	-33.30%	-44.21%	-38.10%	0.70	5.06	100.00%	-325.90%	-325.50%
BCAB	BIOATLA INC	$33.62M	-357.90%	-111.70%	-277.67%	601.20%	69.00	2.35	100.00%	-562.50%	-562.51%
GCTK	GLUCOTRACK INC	$5.75M	N/A	-402.90%	-368.10%	1,766.70%	0.48	3.27	N/A	N/A	N/A
SNGX	SOLIGENIX INC	$4.76M	-274.80%	-129.20%	-518.78%	439.40%	2.15	1.47	N/A	N/A	N/A
CLRB	CELLECTAR BIOSCIENCES INC	$17.27M	-265.50%	-125.70%	-370.52%	391.30%	1.02	2.15	N/A	N/A	N/A
NNOX	NANO-X IMAGING LTD	$239.63M	-32.10%	-28.70%	-33.83%	-74.60%	0.13	4.19	-100.90%	-468.30%	-485.39%
AURA	AURA BIOSCIENCES INC	$383.28M	-64.40%	-54.20%	-53.41%	-72.20%	0.17	12.39	N/A	N/A	N/A
ISPC	ISPECIMEN INC	$6.59M	-395.20%	-121.70%	-1,161.87%	323.10%	8.70	0.23	32.60%	-172.50%	-169.69%
APM	APTORUM GROUP LTD	$10.21M	-18.60%	-23.20%	-34.95%	-24.30%	0.21	0.22	N/A	N/A	N/A
BMEA	BIOMEA FUSION INC	$122.59M	-244.00%	-140.70%	-201.62%	-1,760.40%	1.66	3.68	N/A	N/A	N/A
QTRX	QUANTERIX CORP	$203.85M	-14.50%	-11.80%	-14.19%	-14.80%	0.25	8.29	59.70%	-35.30%	-37.24%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	634	+1.11%	+1.63%	+8.26%	-29.19%	-106.49x	4.77x	-113.22%	-7.27%	-11.64%	+72.95%	Strong Buy
Diagnostics & Research	56	+0.02%	-2.47%	-3.27%	-17.42%	20.31x	3.68x	-2.84%	+7.18%	+15.71%	+12.49%	Buy
Drug Manufacturers - General	19	+0.40%	-2.01%	-0.30%	-10.52%	37.13x	5.94x	+60.35%	+10.38%	+17.86%	+44.87%	Buy
Drug Manufacturers - Specialty & Generic	76	-0.73%	-2.78%	-1.16%	-17.44%	-34.94x	2.21x	+11.10%	+4.22%	+9.47%	+36.51%	Buy
Healthcare Plans	11	+0.30%	+1.05%	-0.09%	-32.06%	14.70x	2.04x	+15.84%	+4.97%	+11.53%	+15.72%	Buy
Health Information Services	53	+0.68%	-0.84%	+1.04%	-53.39%	77.94x	4.23x	+8.42%	+5.33%	+9.22%	+26.25%	Strong Buy
Medical Care Facilities	47	-0.63%	+1.73%	+2.31%	-28.10%	16.56x	5.02x	-187.19%	+6.89%	+15.31%	+14.05%	Buy
Medical Devices	142	-0.10%	-3.04%	-5.16%	-29.50%	29.79x	3.92x	+13.90%	+8.58%	+10.11%	+32.38%	Strong Buy
Medical Distribution	10	+0.23%	+7.25%	+7.77%	+39.80%	28.84x	312.62x	-10.56%	+3.08%	+19.02%	+10.88%	Buy
Medical Instruments & Supplies	55	-0.14%	-2.16%	-3.88%	-63.65%	29.71x	3.28x	+10.49%	+8.41%	+11.17%	+28.18%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Sep 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the #1 top healthcare stock out of 1103 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Embecta (NASDAQ:EMBC) is: Value: A, Growth: A, Momentum: C, Sentiment: B, Safety: D, Financials: A, and AI: C.

Embecta (NASDAQ:EMBC) has a Due Diligence Score of 35, which is 10 points higher than the healthcare sector average of 25. It passed 12 out of 38 due diligence checks and has average fundamentals. Embecta has seen its stock lose -0.71% over the past year, overperforming other healthcare stocks by 31 percentage points.

Embecta has an average 1 year price target of $18.50, an upside of 32.14% from Embecta's current stock price of $14.00.

Embecta stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Embecta, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Aveanna Healthcare Holdings (NASDAQ:AVAH)

Aveanna Healthcare Holdings (NASDAQ:AVAH) is the #2 top healthcare stock out of 1103 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aveanna Healthcare Holdings (NASDAQ:AVAH) is: Value: C, Growth: A, Momentum: B, Sentiment: A, Safety: C, Financials: C, and AI: B.

Aveanna Healthcare Holdings (NASDAQ:AVAH) has a Due Diligence Score of 30, which is 5 points higher than the healthcare sector average of 25. It passed 10 out of 33 due diligence checks and has average fundamentals. Aveanna Healthcare Holdings has seen its stock return 70.58% over the past year, overperforming other healthcare stocks by 102 percentage points.

Aveanna Healthcare Holdings has an average 1 year price target of $7.92, a downside of -10.74% from Aveanna Healthcare Holdings's current stock price of $8.87.

Aveanna Healthcare Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Aveanna Healthcare Holdings, 33.33% have issued a Strong Buy rating, 16.67% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Theravance Biopharma (NASDAQ:TBPH)

Theravance Biopharma (NASDAQ:TBPH) is the #3 top healthcare stock out of 1103 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Theravance Biopharma (NASDAQ:TBPH) is: Value: B, Growth: A, Momentum: C, Sentiment: B, Safety: D, Financials: A, and AI: C.

Theravance Biopharma (NASDAQ:TBPH) has a Due Diligence Score of 39, which is 14 points higher than the healthcare sector average of 25. It passed 12 out of 33 due diligence checks and has average fundamentals. Theravance Biopharma has seen its stock return 79.03% over the past year, overperforming other healthcare stocks by 111 percentage points.

Theravance Biopharma has an average 1 year price target of $25.67, an upside of 77.87% from Theravance Biopharma's current stock price of $14.43.

Theravance Biopharma stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Theravance Biopharma, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 73 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Select Medical Holdings (NYSE:SEM)

Select Medical Holdings (NYSE:SEM) has an annual dividend yield of 14.71%, which is 13 percentage points higher than the healthcare sector average of 2.09%. Select Medical Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Select Medical Holdings's dividend has not shown consistent growth over the last 10 years.

Select Medical Holdings's dividend payout ratio of 35.1% indicates that its high dividend yield is sustainable for the long-term.

2. Cryo Cell International (NYSEMKT:CCEL)

Cryo Cell International (NYSEMKT:CCEL) has an annual dividend yield of 8.62%, which is 7 percentage points higher than the healthcare sector average of 2.09%.

Cryo Cell International's dividend payout ratio of -2,166.7% indicates that its high dividend yield might not be sustainable for the long-term.

3. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 7.45%, which is 5 percentage points higher than the healthcare sector average of 2.09%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.36% in the last day, and down -0.25% over the last week. Enanta Pharmaceuticals was the among the top gainers in the healthcare sector, gaining 91.9% yesterday.

Enanta Pharmaceuticals shares are trading higher after the company reported topline results from its Phase 2b study of Zelicapavir for RSV in high-risk adults.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 55 points higher than the healthcare sector average of 16. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -30.9% in the past year. It has overperformed other stocks in the healthcare sector by 1 percentage points.

2. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 41 points higher than the healthcare sector average of 16. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -0.71% in the past year. It has overperformed other stocks in the healthcare sector by 31 percentage points.

3. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 27 points higher than the healthcare sector average of 16. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 98.04% in the past year. It has overperformed other stocks in the healthcare sector by 130 percentage points.

Are healthcare stocks a good buy now?

51.99% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 40.02% over the next year.

5.18% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.59% of healthcare stocks are rated B (Buy), 46.94% are rated C (Hold), 23.88% are rated D (Sell), and 11.41% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 7.18x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Embecta (NASDAQ:EMBC)

2. Aveanna Healthcare Holdings (NASDAQ:AVAH)

3. Theravance Biopharma (NASDAQ:TBPH)

1. Select Medical Holdings (NYSE:SEM)

2. Cryo Cell International (NYSEMKT:CCEL)

3. Dominari Holdings (NASDAQ:DOMH)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Embecta (NASDAQ:EMBC)

3. Puma Biotechnology (NASDAQ:PBYI)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2025)Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Embecta (NASDAQ:EMBC)

2. Aveanna Healthcare Holdings (NASDAQ:AVAH)

3. Theravance Biopharma (NASDAQ:TBPH)

1. Select Medical Holdings (NYSE:SEM)

2. Cryo Cell International (NYSEMKT:CCEL)

3. Dominari Holdings (NASDAQ:DOMH)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Embecta (NASDAQ:EMBC)

3. Puma Biotechnology (NASDAQ:PBYI)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.